Literature DB >> 22572010

Outcomes of endovascular aneurysm repair with selective internal iliac artery coverage without coil embolization.

Konstantinos O Papazoglou1, George S Sfyroeras, Neofytos Zambas, Konstantinos Konstantinidis, Stavros K Kakkos, Maria Mitka.   

Abstract

OBJECTIVE: Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) that also involve the common iliac artery (CIA) typically is accomplished by endograft limb extension into the external iliac artery (EIA). In order to prevent endoleak, the internal iliac artery (IIA) is usually embolized, or alternatively a branched limb is deployed. However, IIA embolization is associated with longer operative time and increased use of contrast and radiation. It has been our practice not to routinely coil embolize the IIA. The purpose of this study was to present the midterm outcomes of this approach.
METHODS: Between April 1997 and June 2010, 137 patients (130 men; mean age, 70.9 years; range, 45-92 years) underwent EVAR of their AAA and had IIA coverage without coil embolization in 112 patients (no embolization [NE] group) and after coil embolization in 25 patients (coil embolization [CE] group). Anatomic indications for coverage of the IIA without coil embolization included presence of adequate sealing in the distal 5 mm of the CIA, or sealing ring at the origin of the CIA, or IIA diameter <5 mm. Preoperative mean AAA size was 60 ± 14 mm, and mean CIA diameter was 38 ± 13 mm. Postoperative computed tomography (CT) scanning was performed at 1, 6, and 12 months, and yearly thereafter.
RESULTS: Thirty-day mortality was 0.7% (1 of 137 patients). A patient presented with gluteal skin necrosis (0.7%). The incidence of postoperative buttock claudication was not different between the two groups (NE: 15 of 112 patients; CE: 3 of 25 patients; P = .852). Procedure and fluoroscopy time, contrast use, and hospital stay were significantly reduced in the NE group. Patients were followed up for 33 ± 30 months. During follow-up, 44 patients died (32.1%) and in 3 of them (2.2%), death was AAA-related. There was no difference in cumulative survival between the two groups at 1, 2, 3, and 4 years, respectively. Secondary interventions were performed in 20 of 137 patients (14.5%), including three conversions for proximal endoleak. There was no difference between the two groups in the incidence of secondary interventions (NE: 18 of 112 patients; CE: two of 25 patients; P = .301) and freedom from reintervention at 1, 2, 3, and 4 years, respectively. Ten patients (8.9%) from the NE group presented a type II endoleak during follow-up. Seven of them were associated with the covered IIA; none required reintervention.
CONCLUSIONS: Stent graft coverage of the IIA without coil embolization is a safe, simple, and effective maneuver for the treatment of aortoiliac aneurysms, with a low incidence of postoperative complications and reinterventions and acceptable immediate and midterm results.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22572010     DOI: 10.1016/j.jvs.2011.08.063

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

Review 1.  Endovascular management of iliac aneurysmal disease with hypogastric artery preservation.

Authors:  Brian J Schiro; Ripal T Gandhi; Constantino S Peña; Adam R Geronemus; Alex Powell; James F Benenati
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

2.  Outcomes of Endovascular Repair of Aortoiliac Aneurysms and Analyses of Anatomic Suitability for Internal Iliac Artery Preserving Devices in Japanese Patients.

Authors:  Nathan K Itoga; Naoki Fujimura; Keita Hayashi; Hideaki Obara; Hideyuki Shimizu; Jason T Lee
Journal:  Circ J       Date:  2017-02-02       Impact factor: 2.993

3.  Isolated iliac artery aneurysms: a single-centre experience.

Authors:  Rita Fossaceca; Giuseppe Guzzardi; Paolo Cerini; Ignazio Divenuto; Carmelo Stanca; Giuseppe Parziale; Piero Brustia; Alessandro Carriero
Journal:  Radiol Med       Date:  2014-10-28       Impact factor: 3.469

4.  Proximal occlusion of unaffected internal iliac artery versus distal occlusion of aneurysmatic internal iliac artery prior to EVAR: a comparative evaluation of efficacy and clinical outcome.

Authors:  Alexander Dierks; Alexander Sauer; Franziska Wolfschmidt; Nicole Hassold; Richard Kellersmann; Thorsten A Bley; Ralph Kickuth
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

5.  How safe is internal iliac artery embolisation prior to EVAR? A 10-year retrospective review.

Authors:  J G McGarry; A O Alenezi; F P McGrath; M F Given; A N Keeling; D S Moneley; A L Leahy; M J Lee
Journal:  Ir J Med Sci       Date:  2015-11-23       Impact factor: 1.568

6.  8-Year Long-Term Outcome Comparison: Two Ways to Exclude the Internal Iliac Artery during Endovascular Aorta Repair (EVAR) Surgery.

Authors:  Han Luo; Bin Huang; Ding Yuan; Yi Yang; Fei Xiong; Guojun Zeng; Zhoupeng Wu; Xiyang Chen; Xiaojiong Du; Xiaorong Wen; Chuncheng Liu; Hongliu Yang; Jichun Zhao
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

7.  Outcomes of Extended Endovascular Aortic Repair for Aorto-Iliac Aneurysm with Internal Iliac Artery Occlusion.

Authors:  Shunichiro Fujioka; Shigeru Hosaka; Hayato Morimura; Ken Chen; Zhi Chao Wang; Koji Toguchi; Shoji Fukuda; Koki Takizawa; Hiroshi Osawa
Journal:  Ann Vasc Dis       Date:  2017-12-25

8.  Changes in blood flow distribution after hypogastric artery embolization and the ischaemic tolerance of the pelvic circulation.

Authors:  Jun Nitta; Katsuyuki Hoshina; Toshihiko Isaji
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

9.  A Multicenter Assessment of Anatomic Suitability for Iliac Branched Devices in Eastern Asian Patients With Unilateral and Bilateral Aortoiliac Aneurysms.

Authors:  Zheyun Li; Min Zhou; Guili Wang; Tong Yuan; Enci Wang; Yufei Zhao; Xiaolong Shu; Yuchong Zhang; Peng Lin; Weiguo Fu; Lixin Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.